Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $9.52M.
ENTERPRISE VALUE (EV)
$9.52M
CytoMed Therapeutics Limited
Market Cap
$10.83M
Enterprise Value (EV)
$9.52M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| CytoMed Therapeutics Limited (GDTC) | $10.83M | $9.52M |
| Bullfrog AI Holdings, Inc. Common Stock (BFRG)vs › | $10.90M | $4.07M |
| Cerenome, Inc. (CNSY)vs › | $10.67M | $8.35M |
| BioVie Inc. (BIVI)vs › | $11.09M | $2.39M |
| Lifeward Ltd. (LFWD)vs › | $10.55M | $12.18M |
| Caring Brands, Inc. (CABR)vs › | $10.55M | $8.73M |
| Biofrontera Inc. (BFRI)vs › | $11.14M | $13.99M |
| Kiora Pharmaceuticals, Inc. (KPRX)vs › | $11.17M | $4.42M |
| Medicus Pharma Ltd. Common Stock (MDCX)vs › | $10.43M | $14.99M |
| Lisata Therapeutics, Inc. (LSTA)vs › | $11.47M | $1.03M |
Market Cap
$10.83M
Total Debt
$318265.73
Cash
$1.63M
Enterprise Value
$9.52M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
